TESSITORE, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 2.512
EU - Europa 1.902
AS - Asia 719
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 3
Totale 5.144
Nazione #
US - Stati Uniti d'America 2.505
IE - Irlanda 556
CN - Cina 393
IT - Italia 286
SE - Svezia 285
TR - Turchia 244
DE - Germania 228
UA - Ucraina 141
GB - Regno Unito 132
FR - Francia 122
FI - Finlandia 74
CZ - Repubblica Ceca 39
VN - Vietnam 29
SG - Singapore 23
IN - India 16
BE - Belgio 15
KR - Corea 5
AU - Australia 4
CA - Canada 4
BR - Brasile 3
ES - Italia 3
EU - Europa 3
RU - Federazione Russa 3
EE - Estonia 2
HU - Ungheria 2
MY - Malesia 2
NL - Olanda 2
PL - Polonia 2
PT - Portogallo 2
RS - Serbia 2
AT - Austria 1
BG - Bulgaria 1
CH - Svizzera 1
CR - Costa Rica 1
GR - Grecia 1
HK - Hong Kong 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
LT - Lituania 1
MX - Messico 1
NZ - Nuova Zelanda 1
PA - Panama 1
PK - Pakistan 1
RO - Romania 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 5.144
Città #
Chandler 622
Jacksonville 565
Dublin 552
Boardman 137
Izmir 133
Nanjing 98
Princeton 80
San Mateo 80
Lawrence 79
New York 74
Wilmington 74
Ann Arbor 73
L'aquila 55
Beijing 50
Bremen 45
Woodbridge 43
Brno 39
Nanchang 35
Ashburn 34
L’Aquila 33
Milan 30
Shenyang 29
Dong Ket 28
Seattle 25
Los Angeles 24
Tianjin 22
Verona 22
Aquila 20
Kitzingen 20
Singapore 18
Shanghai 16
Brussels 15
Des Moines 15
Jiaxing 15
Mountain View 15
Hebei 14
Helsinki 14
Kunming 13
Munich 13
Philadelphia 12
Zhengzhou 12
Changsha 11
Norwalk 10
Dearborn 9
Pune 9
Guangzhou 8
Jinan 8
Ningbo 8
Redwood City 8
Houston 7
Lissone 7
Rome 7
Taizhou 7
Auburn Hills 6
Bari 6
Berlin 6
Bellante 5
Fremont 5
Menlo Park 5
Caserta 4
Changchun 4
Edinburgh 4
Hangzhou 4
Absecon 3
Clifton 3
Falls Church 3
Haikou 3
Lanzhou 3
Pittsburgh 3
Redmond 3
Acerra 2
Baotou 2
Budapest 2
Cava de' Tirreni 2
Chicago 2
Chieti 2
Cleveland 2
Cugnoli 2
Düsseldorf 2
Frankfurt am Main 2
Giulianova 2
Hefei 2
Madrid 2
Napoli 2
Nuremberg 2
Recale 2
Rho 2
Saint-Fons 2
Simi Valley 2
Tallinn 2
Torino 2
Venezia 2
Warsaw 2
Andover 1
Arzignano 1
Athens 1
Auckland 1
Avezzano 1
Bangkok 1
Belgrade 1
Totale 3.515
Nome #
new bioinformatics approach to identify target genes for dysregulated micrornas in a chemically-induced hepatocarcinoma mouse model 120
Bioinformatics approach to predict target genes for dysregulated microRNAs in hepatocellular carcinoma: Study on a chemically-induced HCC mouse model 115
Cancer secretome and inflammation: The bright and the dark sides of NF-kB 101
Therapeutic Use of MicroRNAs in Cancer 98
The prevalent KRAS exon 2 c.35 G > A mutation in metastatic colorectal cancer patients: a biomarker of worse prognosis and potential benefit of bevacizumab-containing intensive regimens? 98
Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis. 96
KRAS and Two Rare PI3KCA Mutations Coexisting in a Metastatic Colorectal Cancer Patient With Aggressive and Resistant Disease. 95
ANALISI DEL miRNoma NELL’EPATOCARCINOMA INDOTTO DA DIETILNITROSAMINA 94
EFFECTS OF SAFFRON ON HEPATOCARCINOGENESIS PROCESS: A STUDY ON A MOUSE MODEL 94
Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations. 92
Targeting the NF-κB pathway in prostate cancer: a promising therapeutic approach? 90
MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice 87
Development of hepatocellular cancer induced by long term low fat-high carbohydrate diet in a nafld/nash mouse model 87
Next-generation sequencing: Recent applications to the analysis of colorectal cancer 84
The Role of Circulating MicroRNAs as Biomarkers in NAFLD 83
MIRNOME ANALYSIS IN THE PATHOGENESIS OF HEPATOCARCINOMA 81
TrkA alternative splicing: A regulated tumor-promoting switch in human neuroblastoma 78
mir-182 dysregulation in a diet-induced NAFLD-NASH-hepatocellular carcinoma mouse model 78
Characterization of a novel HLA-Cw*02 variant, Cw*0208, in a Caucasian individual 76
development of hepatocellular cancer in a murine model of nonalcoholic steatohepatitis induced by use of low-fat/high carbohydrate diet 76
A KRAS and dual concomitant PI3KCA mutations in a metastatic colorectal cancer patient with aggressive and resistant disease 75
two simulteneous and very uncommom pi3kca mutations in a liver metastasis from colorectal cancer patient with aggressive and resistant disease 75
Involvement of an arachidonic-acid-dependent pathway in the interferon-beta-mediated expression of C202 gene in Ehrlich-ascites-tumor cells 75
Prognostic relevance of KRAS genotype and the prevalent C.35 G > a mutation in metastatic colorectal cancer (MCRC) patients fitting for intensive FIr-B/FOx triplet chemotherapy plus bevacizumab 74
Angiotensin II stimulates intercellular adhesion molecule-1(ICAM1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo 73
crosstalk between nf-kb and shh pathways in prostate cancer 72
Identification of the novel allele B*4427 and a confirmatory sequence (B*44022) 70
Serum biomarkers identification by mass spectrometry in high-mortality tumors. 69
Pharmacogenetics and clinical oncology: a new deal for personalized therapies 68
MicroRNAs in the DNA Damage/Repair Network and Cancer 67
Novel P53 mutations detected by FAMA in colorectal cancers 66
New mutations and protein variants of NBSI are identified in cancer cell lines 65
Two gamma-interferon-activation sites (GAS) on the promoter of the human intercellular adhesion molecule 1 (ICAM-1) gene are required for induction of transcription by IFN-gamma 65
Can analysis of the molecular status of the p53 gene contribute to improving the therapeutic strategy for breast carcinoma? 65
Prognostic relevance of PIK3CA mutations in breast cancer patients treated with primary dose-dense epirubicin/cyclophosphamide -> dose-dense docetaxel 65
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 65
KCTD11 tumor suppressor gene expression is reduced in prostate adenocarcinoma 64
The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages. 63
Identification of the uncommon allele HLA-A*7403 in a Caucasian renal transplant cadaveric donor: Extension of the exon 4 sequence 62
the role of kctd11 tumor suppressor gene in prostate cancer 62
Reverse-phase protein microarray highlights HER2 signaling activation in immunohistochemistry/FISH/HER2-negative breast cancers. 62
MICA∗078: A novel allele identified in a moroccan individual affected by celiac disease. 61
Identification of a novel HLA-DRB1*11 allele: DRB1*1152 61
Effective treatment of a platinum-resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition 61
MiRNome analysis in high-fat diet-induced hepatocarcinoma. 60
Identification of a novel allele variant of HLA-B*57 in a Caucasian Moroccan individual: B*57032 58
Human leukocyte antigen-A, -B, and -Cw polymorphism in a Berber population from North Morocco using sequence-based typing 57
A NEW ALLELE, MICA*078, IDENTIFIED IN A MOROCCAN INDIVIDUAL WITH CELIAC DISEASE 57
Prognostic value of p53 molecular status in high-risk primary breast cancer 57
Prognostic significance of P53 mutations in high risk node positive breast cancer patients 57
Role of bcr-abl in the regulation and inhibition of apoptosis 56
Efficacy and tolerability of Everolimus-Exemestane combination therapy in metastatic breast cancer patients: experience in Real Life 56
Identification of a novel HLA-A*02 allele, A*027401* 56
Analytical scanning of p53 mutations by FAMA (fluorescence assisted mismatch analysis) in colorectal cancers and preliminary prognostic findings. 55
Increased CD1D polymorphism: identification of two novel alleles, CD1D*03 and *04, in individuals from Morocco. 54
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 52
High sensitivity of detectionof TP53 somatic mutations by fluorescence-assisted mismatch analysis 52
Emerging role of isomirs in cancer: State of the art and recent advances 52
Smart hydrogel particles: Biomarker harvesting: One-step affinity purification, size exclusion, and protection against degradation 51
An initial characterization of the serum phosphoproteome. 51
Prenatal diagnosis of a rhodopsin mutation using chemical cleavage of the mismatch 50
Concurrent RAS and RAS/BRAF V600E variants in colorectal cancer: more frequent than expected? 50
Serum low-molecular-weight protein fractionation for biomarker discovery 49
SMO-M2 mutation does not support cell-autonomous Hedgehog activity in cerebellar granule cell precursors 48
A Simplified Genomic Profiling Approach Predicts Outcome in Metastatic Colorectal Cancer. 47
Mass spectrometry driven discovery proteomics of serum from mice with human ovarian cancer resulted in identification of a potential cancer-origin biomarker that correlates with peritoneal tumor burden. 46
IDENTIFICATION OF TWO NOVEL ALLELES, CD1D*03 AND*04, IN INDIVIDUALS FROM MOROCCO 45
MRE11 inhibition highlights a replication stress-dependent vulnerability of MYCN-driven tumors 45
Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma 44
MicroRNAs Expression in Response to rhNGF in Epithelial Corneal Cells: Focus on Neurotrophin Signaling Pathway 44
Applications of Next Generation Sequencing to the Analysis of Familial Breast/Ovarian Cancer 43
Circulating micrornas as prognostic and therapeutic biomarkers in breast cancer molecular subtypes 43
Ultrasound-based method for the identification of novel microrna biomarkers in prostate cancer 43
Low Radiation Environment Switches the Overgrowth-Induced Cell Apoptosis Toward Autophagy 42
null 38
Longitudinal monitoring of mRNA levels of regulatory T cell biomarkers by using non-invasive strategies to predict outcome in renal transplantation 37
Codon optimization by 0-1 linear programming 36
null 35
Long-term abuse of a high-carbohydrate diet is as harmful as a high-fat diet for development and progression of liver injury in a mouse model of NAFLD/NASH 35
Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status. 34
Neuroprotective effects of human amniotic fluid stem cells-derived secretome in an ischemia/reperfusion model 34
A European observational study to evaluate the safety and the effectiveness of safinamide in routine clinical practice: The SynapSES trial 34
Detection of NBS1 (Nibrin) mutations in breast and ovarian cancer 33
MicroRNAs expression analysis in high-fat diet induced NAFLD-NASH-HCC progression: study on C57BL/6J mice 27
Classification of tumor types using XGBoost machine learning model: a vector space transformation of genomic alterations 22
MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression 18
Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells 9
A method to comprehensively identify germline SNVs, INDELs and CNVs from whole exome sequencing data of BRCA1/2 negative breast cancer patients 8
Role of Breast Cancer Risk Estimation Models to Identify Women Eligible for Genetic Testing and Risk-Reducing Surgery 8
MicroRNA profiling in women with migraine: effects of CGRP-targeting treatment 7
Role of the Molecular Tumor Board for the Personalized Treatment of Patients with Metastatic Breast Cancer: A Focus on the State of the Art in Italy 6
Takotsubo Syndrome during Pertuzumab and Trastuzumab Therapy for HER2-Positive Metastatic Breast Cancer 6
Totale 5.375
Categoria #
all - tutte 20.416
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.416


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020643 134 6 84 7 2 77 129 11 85 26 5 77
2020/2021756 26 75 6 75 89 36 99 39 83 39 129 60
2021/2022514 35 25 128 43 21 5 9 28 35 9 33 143
2022/20231.684 106 125 30 213 167 184 2 86 682 11 56 22
2023/2024474 46 26 19 41 31 118 2 45 0 18 29 99
2024/202552 52 0 0 0 0 0 0 0 0 0 0 0
Totale 5.375